FERMENTA BIOTECH LIMITEDFERMENTA BIOTECH LIMITEDFERMENTA BIOTECH LIMITED

FERMENTA BIOTECH LIMITED

No trades
See on Supercharts

FERMENTA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Fermenta Biotech Ltd. engages in the manufacturing and supply of Vitamin D3. It produces a range of variants such as crystalline, oil, resin in oil, cold water dispersible (CWD) and feed grade powder, which can be used in applications like injectables, soft gel capsules, premixes, as well as food and beverage fortification. The firm operates through the following segments: Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment engages in manufacturing and selling of chemicals, Drugs and enzymes. The property segment engages in renting of properties. The company was founded by Vijay Kumar Raju Datla on May 1, 1951 and is headquartered in Mumbai, India.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

FERMENTA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company